Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Vladimir, Son"'
Autor:
Yuping Dong, Robert Hamlin, Daniel Gaudet, Erik S.G. Stroes, Lesley J. Burgess, Robert Pordy, Nagwa Khilla, Shazia Ali, C. Ebenbichler, Seth J. Baum, Robert S. Rosenson, Vladimir Son
Publikováno v:
New England journal of medicine, 383(24), 2307-2319. Massachussetts Medical Society
Patients with refractory hypercholesterolemia, who have high low-density lipoprotein (LDL) cholesterol levels despite treatment with lipid-lowering therapies at maximum tolerated doses, have an increased risk of atherosclerosis. In such patients, the
Autor:
Yi Zhang, Robert Pordy, Alberico L. Catapano, Vladimir Son, Evelyn Gasparino, Shazia Ali, Daniel A. Gipe, Mariko Harada-Shiba
Publikováno v:
Atherosclerosis. 314:33-40
Evinacumab, an angiopoietin-like protein 3 monoclonal antibody, reduced low-density lipoprotein cholesterol (LDL-C) significantly in a Phase 2 study of patients with homozygous familial hypercholesterolemia. In this double-blind, placebo-controlled P
Autor:
Robert Vitti, Friedrich Asmus, Karen W. Chu, Jeffrey S. Heier, Sunil S. Patel, Sergio Leal, David M. Brown, John W. Kitchens, Thomas Schmelter, Lorah Perlee, Charles C. Wykoff, Vladimir Son, Nadia K Waheed
Publikováno v:
Ophthalmology. 127:211-220
Purpose To compare the efficacy and safety of intravitreal aflibercept + anti–platelet-derived growth factor receptor β (PDGFRβ) combination with intravitreal aflibercept injection (IAI) monotherapy in patients with treatment-naive neovascular ag
Autor:
Brian G, Feagan, Stefan, Schreiber, Anita, Afzali, Florian, Rieder, Jeffrey, Hyams, Kanthi, Kollengode, Jared, Pearlman, Vladimir, Son, Cecilia, Marta, Douglas C, Wolf, Geert G, D'Haens
Publikováno v:
Contemporary clinical trials, 122:106958. Elsevier Inc.
Ozanimod, an oral sphingosine 1-phosphate receptor modulator currently approved for the treatment of moderately to severely active ulcerative colitis and relapsing multiple sclerosis, showed clinical, endoscopic, and histological benefit in the phase
Autor:
Daniel J. Rader, Manish P. Ponda, Robert S. Rosenson, Robert Pordy, Patrick M. Moriarty, Seth J. Baum, Vladimir Son, Christie M. Ballantyne, Daniel Gaudet, E.E. Kershaw, Poulabi Banerjee, Jean Bergeron, Paolo Rubba
Publikováno v:
Atherosclerosis. 331:e293
Autor:
Daniel A. Gipe, Alberico L. Catapano, Mariko Harada-Shiba, Robert Pordy, Shazia Ali, Vladimir Son, Evelyn Gasparino
Publikováno v:
Journal of Clinical Lipidology. 14:581
Autor:
Jeffrey S, Heier, Charles C, Wykoff, Nadia K, Waheed, John W, Kitchens, Sunil S, Patel, Robert, Vitti, Lorah, Perlee, Karen W, Chu, Sergio, Leal, Friedrich, Asmus, Vladimir, Son, Thomas, Schmelter, David M, Brown
Publikováno v:
Ophthalmology. 127(2)
To compare the efficacy and safety of intravitreal aflibercept + anti-platelet-derived growth factor receptor β (PDGFRβ) combination with intravitreal aflibercept injection (IAI) monotherapy in patients with treatment-naïve neovascular age-related
Autor:
Igor A. Presniakov, Vladimir Son, Sabine Wurmehl, Alexey V. Sobolev, Olga S. Volkova, Igor Morozov, Maria Roslova, Bernd Büchner, Alexander N. Vasiliev, A. I. Boltalin
Detailed 57Fe Mossbauer spectroscopy measurements on superconducting NaFeAs powder samples have been performed in the temperature range 13 K < T < 300 K. The 57Fe spectra recorded in the paramagnetic range (T > TN ~ 46 K) were discussed supposing tha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e690dbe8fe3898a43a997c6f69e70cc6
http://arxiv.org/abs/1211.5967
http://arxiv.org/abs/1211.5967